Nanollose Limited Logo

Nanollose Limited

NC6.AX

(1.0)
Stock Price

0,02 AUD

-478.01% ROA

3324.86% ROE

-2.65x PER

Market Cap.

3.268.114,00 AUD

-19.01% DER

0% Yield

-9251.68% NPM

Nanollose Limited Stock Analysis

Nanollose Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Nanollose Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (2%), which means it has a small amount of debt compared to the ownership it holds

2 PBV

The stock's PBV ratio (2.32x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

3 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

4 ROE

The stock's ROE indicates a negative return (-68.21%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-82.18%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Nanollose Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Nanollose Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

Nanollose Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Nanollose Limited Revenue
Year Revenue Growth
2015 0
2016 11.630 100%
2017 0 0%
2018 117.167 100%
2019 235.846 50.32%
2020 0 0%
2020 461.847 100%
2021 322.859 -43.05%
2022 224.611 -43.74%
2023 38.101 -489.51%
2024 46.504 18.07%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Nanollose Limited Research and Development Expenses
Year Research and Development Expenses Growth
2015 1.048
2016 9.698 89.19%
2017 299.418 96.76%
2018 610.613 50.96%
2019 725.411 15.83%
2020 474.557 -52.86%
2020 474.557 0%
2021 393.433 -20.62%
2022 448.164 12.21%
2023 353.875 -26.64%
2024 531.608 33.43%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Nanollose Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2015 0
2016 5.000 100%
2017 154.758 96.77%
2018 574.271 73.05%
2019 874.306 34.32%
2020 871.845 -0.28%
2020 871.845 0%
2021 306.725 -184.24%
2022 718.525 57.31%
2023 74.099 -869.68%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Nanollose Limited EBITDA
Year EBITDA Growth
2015 0
2016 -9.410 100%
2017 -817.440 98.85%
2018 -1.893.870 56.84%
2019 -2.252.460 15.92%
2020 -1.178.424 -91.14%
2020 -1.746.100 32.51%
2021 -1.171.510 -49.05%
2022 -1.712.840 31.6%
2023 -1.507.550 -13.62%
2024 -2.453.720 38.56%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Nanollose Limited Gross Profit
Year Gross Profit Growth
2015 0
2016 11.630 100%
2017 -484 2502.89%
2018 110.735 100.44%
2019 203.688 45.63%
2020 0 0%
2020 408.321 100%
2021 265.911 -53.56%
2022 159.607 -66.6%
2023 -832.502 119.17%
2024 -1.410.176 40.96%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Nanollose Limited Net Profit
Year Net Profit Growth
2015 -2.074
2016 -9.907 79.07%
2017 -820.346 98.79%
2018 -1.730.214 52.59%
2019 -2.003.995 13.66%
2020 -1.235.489 -62.2%
2020 -1.235.489 0%
2021 -931.045 -32.7%
2022 -1.566.504 40.57%
2023 -1.345.656 -16.41%
2024 -2.558.596 47.41%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Nanollose Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Nanollose Limited Free Cashflow
Year Free Cashflow Growth
2015 -2.042
2016 -3.404 40.01%
2017 -579.003 99.41%
2018 -1.655.532 65.03%
2019 -1.899.777 12.86%
2020 -946.685 -100.68%
2021 -1.007.339 6.02%
2022 -1.387.658 27.41%
2023 -1.011.430 -37.2%
2024 -518.877 -94.93%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Nanollose Limited Operating Cashflow
Year Operating Cashflow Growth
2015 -2.042
2016 -3.404 40.01%
2017 -574.014 99.41%
2018 -1.575.336 63.56%
2019 -1.862.568 15.42%
2020 -945.594 -96.97%
2021 -935.186 -1.11%
2022 -1.382.306 32.35%
2023 -1.011.430 -36.67%
2024 -518.877 -94.93%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Nanollose Limited Capital Expenditure
Year Capital Expenditure Growth
2015 0
2016 0 0%
2017 4.989 100%
2018 80.196 93.78%
2019 37.209 -115.53%
2020 1.091 -3310.54%
2021 72.153 98.49%
2022 5.352 -1248.15%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Nanollose Limited Equity
Year Equity Growth
2015 -1.723
2016 -11.630 85.18%
2017 4.277.702 100.27%
2018 3.042.270 -40.61%
2019 1.119.565 -171.74%
2020 785.218 -42.58%
2021 2.873.808 72.68%
2022 1.728.319 -66.28%
2023 451.632 -282.68%
2024 -223.692 301.9%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Nanollose Limited Assets
Year Assets Growth
2015 14.277
2016 10.314 -38.42%
2017 4.411.352 99.77%
2018 3.202.645 -37.74%
2019 1.277.783 -150.64%
2020 1.021.970 -25.03%
2021 3.381.642 69.78%
2022 1.909.828 -77.07%
2023 633.238 -201.6%
2024 241.951 -161.72%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Nanollose Limited Liabilities
Year Liabilities Growth
2015 16.000
2016 21.944 27.09%
2017 133.650 83.58%
2018 160.375 16.66%
2019 158.218 -1.36%
2020 236.752 33.17%
2021 507.834 53.38%
2022 181.509 -179.78%
2023 181.606 0.05%
2024 465.643 61%

Nanollose Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.01
Price to Earning Ratio
-2.65x
Price To Sales Ratio
261.43x
POCF Ratio
-3.4
PFCF Ratio
-3.63
Price to Book Ratio
-13.7
EV to Sales
255.33
EV Over EBITDA
-2.28
EV to Operating CashFlow
-3.54
EV to FreeCashFlow
-3.54
Earnings Yield
-0.38
FreeCashFlow Yield
-0.28
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.01
Graham NetNet
-0

Income Statement Metrics

Net Income per Share
-0.01
Income Quality
0.78
ROE
33.25
Return On Assets
-4.78
Return On Capital Employed
6.42
Net Income per EBT
0.8
EBT Per Ebit
1
Ebit per Revenue
-114.87
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
3.42
Research & Developement to Revenue
28.91
Stock Based Compensation to Revenue
2.14
Gross Profit Margin
-62.33
Operating Profit Margin
-114.87
Pretax Profit Margin
-114.94
Net Profit Margin
-92.52

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
6.38
Return on Tangible Assets
-4.78
Days Sales Outstanding
309.26
Days Payables Outstanding
153.02
Days of Inventory on Hand
0
Receivables Turnover
1.18
Payables Turnover
2.39
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
-0
Shareholders Equity per Share
-0
Interest Debt per Share
0
Debt to Equity
-0.19
Debt to Assets
0.18
Net Debt to EBITDA
0.05
Current Ratio
0.4
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-223692
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Nanollose Limited Dividends
Year Dividends Growth

Nanollose Limited Profile

About Nanollose Limited

Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of the microbial nanocellulose technology in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre; and Jelli Grow, an alternative seed germination and plant growing material. Its products are used in textiles, nonwoven fabric, and other industries. The company was incorporated in 2014 and is based in Nedlands, Australia.

CEO
Dr. Wayne Morris Best BSc (Hon
Employee
0
Address
CPC
Nedlands, 6009

Nanollose Limited Executives & BODs

Nanollose Limited Executives & BODs
# Name Age
1 Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG
Company Secretary
70
2 Dr. Wayne Morris Best BSc (Hons), DIC, FRACI, GAICD, Ph.D.
Executive Chairman
70

Nanollose Limited Competitors